United States · Bill · HR
H.R. 863 (116th)
DXM Abuse Prevention Act of 2019
Introduced
30 January 2019
Last action
—
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
DXM Abuse Prevention Act of 2019 This bill addresses the sale and distribution of dextromethorphan (DXM). Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer. The bill also establishes restrictions on (1) the sale of over-the-counter drugs containing DXM, and (2) the distribution of bulk DXM.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 30 January 2019
Introduced in House (PDF)
Introduced in House · EN · 30 January 2019
Introduced in House
summary · EN · 30 January 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/863
- Open data entity: https://api.congress.gov/v3/bill/116/hr/863